Published in Br J Haematol on September 01, 1993
Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis (2009) 0.88
Neurologic melioidosis. Am J Trop Med Hyg (2013) 0.83
Neuromelioidosis: a series of seven cases in Hainan province, China. J Int Med Res (2017) 0.75
Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell (2001) 6.10
The RNA-DNA hybrid maintains the register of transcription by preventing backtracking of RNA polymerase. Cell (1997) 4.10
A structural model of transcription elongation. Science (2000) 4.09
Photoradiation therapy for the treatment of malignant tumors. Cancer Res (1978) 4.01
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
Transcript cleavage factors from E. coli. Cell (1993) 3.78
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem (1993) 3.07
Discontinuous mechanism of transcription elongation. Science (1994) 2.91
Withdrawal of enzyme replacement therapy in Gaucher's disease. Br J Haematol (2000) 2.90
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Reliability of psychiatrists' ratings in community case finding. Am J Public Health Nations Health (1967) 2.64
Transcription processivity: protein-DNA interactions holding together the elongation complex. Science (1996) 2.58
Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM (1996) 2.54
Intrinsic transcript cleavage activity of RNA polymerase. Proc Natl Acad Sci U S A (1995) 2.45
Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet (1998) 2.37
How B12 deficiency can impact on the individual and how society can impact on B12 deficiency. Isr Med Assoc J (2001) 2.36
Exercise-induced bronchial lability in children with a history of wheezy bronchitis. Arch Dis Child (1972) 2.23
Operationalizing a bedside pen entry notebook clinical database system in consultation-liaison psychiatry. Gen Hosp Psychiatry (1995) 2.15
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med (1994) 2.13
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Mapping of catalytic residues in the RNA polymerase active center. Science (1996) 1.91
Recombinant Escherichia coli RNA polymerase: purification of individually overexpressed subunits and in vitro assembly. Protein Expr Purif (1993) 1.89
Location, structure, and function of the target of a transcriptional activator protein. Genes Dev (1994) 1.88
Coupling between transcription termination and RNA polymerase inchworming. Cell (1995) 1.86
GreA protein: a transcription elongation factor from Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.85
Rapid RNA polymerase genetics: one-day, no-column preparation of reconstituted recombinant Escherichia coli RNA polymerase. Proc Natl Acad Sci U S A (1995) 1.85
Crystal structure of the GreA transcript cleavage factor from Escherichia coli. Nature (1995) 1.79
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Reliability of newly trained raters in community case finding. Am J Public Health Nations Health (1967) 1.71
Lung involvement and enzyme replacement therapy in Gaucher's disease. QJM (2001) 1.70
Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve disease. J Am Coll Cardiol (1991) 1.57
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol (2002) 1.55
Histidine-tagged RNA polymerase of Escherichia coli and transcription in solid phase. Methods Enzymol (1996) 1.53
Protein-RNA interactions in the active center of transcription elongation complex. Proc Natl Acad Sci U S A (1996) 1.52
RifR mutations in the beginning of the Escherichia coli rpoB gene. Mol Gen Genet (1994) 1.52
Two modes of transcription initiation in vitro at the rrnB P1 promoter of Escherichia coli. J Biol Chem (1993) 1.51
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst (1979) 1.50
Histidine-tagged RNA polymerase: dissection of the transcription cycle using immobilized enzyme. Gene (1993) 1.49
Lead poisoning in a West Bank Arab Village. Arch Intern Med (1984) 1.49
Esophageal involvement in chronic granulomatous disease. Case report and review. Pediatr Radiol (1995) 1.48
Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol (1995) 1.47
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
lac repressor acts by modifying the initial transcribing complex so that it cannot leave the promoter. Cell (1991) 1.44
High prevalence of low serum vitamin B12 in a multi-ethnic Israeli population. Br J Haematol (2001) 1.43
Replacement therapy with imiglucerase for type 1 Gaucher's disease. Lancet (1995) 1.42
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Mapping of the priming substrate contacts in the active center of Escherichia coli RNA polymerase. J Biol Chem (1991) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Skeletal manifestations in Gaucher disease: presentation and treatment. Isr Med Assoc J (1999) 1.40
Streptolydigin-resistant mutants in an evolutionarily conserved region of the beta' subunit of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.38
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Recombinant RNA polymerase: inducible overexpression, purification and assembly of Escherichia coli rpo gene products. Gene (1990) 1.36
The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.35
Cytokines in Gaucher's disease. Eur Cytokine Netw (1999) 1.32
Mechanistic model of the elongation complex of Escherichia coli RNA polymerase. Cold Spring Harb Symp Quant Biol (1998) 1.28
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Blocking of the initiation-to-elongation transition by a transdominant RNA polymerase mutation. Science (1990) 1.24
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
The effect of atmospheric ions on the respiratory system of infants. Pediatrics (1966) 1.22
Modular organization of the catalytic center of RNA polymerase. Proc Natl Acad Sci U S A (1997) 1.22
A non-essential domain of Escherichia coli RNA polymerase required for the action of the termination factor Alc. J Biol Chem (1994) 1.20
An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci (1995) 1.20
Spatial organization of transcription elongation complex in Escherichia coli. Science (1998) 1.20
Structural modules of the large subunits of RNA polymerase. Introducing archaebacterial and chloroplast split sites in the beta and beta' subunits of Escherichia coli RNA polymerase. J Biol Chem (1996) 1.20
Mapping of a contact for the RNA 3' terminus in the largest subunit of RNA polymerase. J Biol Chem (1991) 1.19
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
The sigma subunit conserved region 3 is part of "5'-face" of active center of Escherichia coli RNA polymerase. J Biol Chem (1994) 1.16
Diversity of beta-globin mutations in Israeli ethnic groups reflects recent historic events. Am J Hum Genet (1994) 1.16
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. Proc Natl Acad Sci U S A (1994) 1.12
Escherichia coli RNA polymerase holoenzyme: rapid reconstitution from recombinant alpha, beta, beta', and sigma subunits. Methods Enzymol (1996) 1.09
Gaucher's disease. Lancet (2001) 1.09
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
A beta subunit mutation disrupting the catalytic function of Escherichia coli RNA polymerase. Proc Natl Acad Sci U S A (1991) 1.09
Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease. Br J Haematol (1999) 1.08
Dominant lethal mutations near the 5' substrate binding site affect RNA polymerase propagation. J Biol Chem (1993) 1.08
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Active center rearrangement in RNA polymerase initiation complex. J Biol Chem (1993) 1.07
Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2012) 1.07
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci (1970) 1.05
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci (1972) 1.05
In vitro transcription and isolation of a polycistronic RNA product of the T4 tRNA operon. Nature (1978) 1.05
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
Topology of the product binding site in RNA polymerase revealed by transcript slippage at the phage lambda PL promoter. J Biol Chem (1994) 1.04
Inappropriate antidiuretic hormone secretion in an infant with severe pneumonia. Am J Dis Child (1975) 1.03
Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol (1996) 1.02
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest (1981) 1.02
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02